Chemotherapy‐Mediated Induction of PD‐L1 via SEI1 Facilitates Myeloma Immune Evasion
Advanced Science · 2025
DOI: 10.1002/advs.202411082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Rui Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China. Hauptthemen laut MEDLINE: Multiple Myeloma, B7-H1 Antigen, Immune Evasion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Program.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Multiple myeloma (MM) is a plasma cell‐derived malignancy. While immune checkpoint blockade immunotherapy has advanced myeloma treatment, chemotherapy remains the primary therapy. How chemotherapy interacts with immune checkpoint expression and impacts immunotherapy efficacy remains unclear. Here it is discovered that chemotherapeutic drugs induce DNA damage and activate the cyclic guanosine monophosphate (GMP)–adenosine monophosphate (AMP) synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway. This activation promotes phosphorylation of the interferon regulatory factor 7 (IRF7), which binds to the promoter region of SERTA‐containing domain 1 ( SERTAD1 , also called SEI1 ) gene to enhance its transcription. The SEI1 directly interacts with the enhancer factors CREB‐binding protein (CBP)/p300 and RNA polymerase II (pol II)‐associated factor 1 (PAF1) complex, promoting transcriptional activity and leading to upregulation of programmed death ligand‐1 (PD‐L1) and immune escape in myeloma. Both in vitro and in vivo experiments demonstrate that treating myeloma cells with PD‐L1 antibodies post‐chemotherapy significantly enhances the killing efficiency of activated T cells, compared to sequential treatment with chemotherapy and PD‐L1 antibodies. This research not only uncovers a pivotal regulatory mechanism of PD‐L1 upregulation but also provides a compelling rationale for the integration of chemotherapy and immunotherapy in myeloma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
- School of Life Sciences, Anhui Medical University, Hefei, Anhui, 230032, China.
- Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361102, China.
- Department of Hematology, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, 361102, China.
- Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
- Shenzhen Research Institute of Xiamen University, Shenzhen, Guangdong, 518057, China.
ORCID-Profile: Huan Liu
Förderung
- Natural Science Foundation of Fujian Province
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Program
- Science Fund for Distinguished Young Scholars of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, R., Li, Z., Fang, Z., Li, Z., Yang, D., Li, Y., Liu, S., Liu, Z., Liu, R., & Liu, H. (2025). Chemotherapy‐Mediated Induction of PD‐L1 via SEI1 Facilitates Myeloma Immune Evasion. Advanced Science. https://doi.org/10.1002/advs.202411082
Vancouver
Chen R, Li Z, Fang Z, Li Z, Yang D, Li Y, et al. Chemotherapy‐Mediated Induction of PD‐L1 via SEI1 Facilitates Myeloma Immune Evasion. Advanced Science. 2025. doi:10.1002/advs.202411082
BibTeX
@article{Chen2025,
author = {Chen, Rui and Li, Zongwei and Fang, Zhihong and Li, Zou and Yang, Daoyan and Li, Yuan and Liu, Shurong and Liu, Zhiqiang and Liu, Rui and Liu, Huan},
title = {Chemotherapy‐Mediated Induction of PD‐L1 via SEI1 Facilitates Myeloma Immune Evasion},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411082}
}
EUVIMED